presentazione di powerpoint · today tomorrow the neuromodulation market revenue data from...
TRANSCRIPT
Wiringless Implantable Stretchable Electronics
WISE vison
Fast market entry with Cortical Grids.
Market Breakthrough with Foldable SCS paddles.
We will revolutionize
leads manufacturing
First to produce Neuro-leads: highly conformable, completely stretchable, minimally invasive.
The Neuro-leads Scenario
Neuromodulation therapies:
Chronic pain (SCS)
Parkinson’s disease
Dystonia
Epilepsy
Depression
and many others …
Neuromonitoring Electrodes(iEEG)
NeurostimulationLeads (SCS, DBS)
Acute application:
Intra-Operative Neuro-Monitoring (IONM)
Identification of epileptogenic zones
Today Tomorrow
The Neuromodulation Market
Revenue data from Corporate Annual Reports (2005-2016)
• Neuromodulation Rev. (2016): $3.4B
• 15% of Revenues come from Leads
Constant growth by
~10%
The limits of current leads technology
are major roadblock on the way to
new therapies.
Current Market Problems
!
Neuromodulation LeadsNeuromonitoring Electrodes
INVASIVE
MIGRATION
BREAKAGE
LIMITED COMPLEXITY
HIGH PROD. COSTS
Bulky
Poorly conformable
Poorly stretchable
Low resolution
Hand assembled
Arbitrarily thin
Highly conformable
Highly stretchable
High resolution
Automation
LOW INVASIVITY
NO MIGRATION
NO BREAKAGE
UNLIMITED COMPLEXITY
LOWER PROD. COSTS
Neuromonitoring Electrodes Neuromodulation Leads
The WISE Solution: Next-generation leads
Neuro2World Connection
Soft tissue Hard electronic devices
Mechanical
mismatch
Hard metal leads
Conductiveelastomer
Device
Young’s Modulus (Pa)
The WISE technology
Stretchable
polymer
Supersonic
cluster beam
source
Conductive
nanoparticles (Pt, Ir)
Unrivaled stretchability
Arbitrarily soft & thin substrate
Biocompatible (ISO 10993-1:2009 Tests)
Easy manufacturing Conductive stretchable
nanocomposite
PCT/EP2011/054903
Easy Manufacturing
Arbitrarily soft & thin substrate (cold technology)
No Engineering Limitations
Any shape
Any size (from m to cm)
200 m4 mm
Any polymer
Polyurethanes
PMMAsSilicones
Robust Interconnection to standard electronics
wire
Robust interconnection
High risk of breakage
Need for wiring
Patent: PCT Nr. PCT/IB2017/053056
Cortical Grids: Overview
Intra-operative or Acute: max 29 days
Monitoring/mapping the cortical surface during brain surgery (IOM) or before the surgical treatment of Epilepsy (ECoG)
Single-use
Cortical grids are used for the recording, monitoring and stimulation of electrical signal on the surface level of the brain.
WISE’s Cortical Grids
Cortical Grids: WISE vs. Commercial
COMMERCIAL
Neuromodulation Leads: SCS Paddles
The first “Foldable SCS Paddle lead”
An SCS lead with all the advantages of a
Paddle lead
implanted byminimally invasive surgery
as a Percutaneous lead
SCS leads: Paddle vs. Percutaneous
PercutaneousPaddles
Two types of Leads are used for SCS:
Better stim. (directional)
Invasive/Costly insertion
Precise stim. spot (grid)
Complex removal
Worse stim. (non directional)
Easy/Cheap insertion
Less Precise stim. spot
Easier removal
Surgically placed Implanted through a needle
WISE’s Foldable SCS Paddle lead
This will change the
SCS paradigm
Requires WISE’s technology
WISE’s Foldable SCS Paddle lead
WISE’s Foldable SCS Paddle lead
Foldable in less than 4 mm
Product in development
Patenting & kickoff
WISE’s Roadmap
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Angel round
Agite!2011
Technology Consolidation
Patenting & kickoff
WISE’s Roadmap
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Angel round
Seed round
2012
250,000€ Investment
Prototyping & Animal testing
Technology Consolidation
Patenting & kickoff
WISE’s Roadmap
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Angel round
Seed round
Seed+ round
€1M
2013
Prototyping & Animal testing
Technology Consolidation
Patenting & kickoff
WISE’s Roadmap
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Angel round
Seed round
VC series A
€3M
Seed+ round
€1M
2015
CE mark / Market
Cortical Grids
Engineering,
Regulatory &
Clinical Trials
Prototyping & Animal testing
Technology Consolidation
Patenting & kickoff
Foldable Paddle
Engineering,
Preclinical &
Clinical Trials
CE mark / Market
WISE’s Roadmap
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Angel round
Seed round
VC series B
€6.5M
VC series A
€3M
Seed+ round
€1M
CE mark / Market
Cortical Grids
Engineering,
Regulatory &
Clinical Trials
Tot. €11M
WISE Factory
• 1000 m2 facility• Offices, Labs and Production• 120 m2 of ISO 7 cleanrooms
Production
R&D
Offices
120 m2 ISO7 Cleanroom
R&D Lab
Production Lab
Offices
WISE’s Team